+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Iron Deficiency Anemia Therapy - Global Strategic Business Report

  • PDF Icon

    Report

  • 192 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309485
Description Jump to:

Global Iron Deficiency Anemia Therapy Market to Reach $23.9 Billion by 2030

The global market for Iron Deficiency Anemia Therapy estimated at US$13.3 Billion in the year 2022, is projected to reach a revised size of US$23.9 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030. Oral Iron Therapy, one of the segments analyzed in the report, is projected to record 6.9% CAGR and reach US$11.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Parenteral Iron Therapy segment is readjusted to a revised 8.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 11.1% CAGR

The Iron Deficiency Anemia Therapy market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Select Competitors (Total 38 Featured) -

  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Keryx Biopharmaceuticals, Inc.
  • Luitpold Pharmaceuticals, Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Iron Deficiency Anemia Therapy - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Iron Deficiency Anemia Therapy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 4: World 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 7: World 16-Year Perspective for Oral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 10: World 16-Year Perspective for Parenteral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 13: World 16-Year Perspective for Red Blood Cell Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 15: USA Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 16: USA 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 18: Canada Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 19: Canada 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
JAPAN
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: Japan Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 22: Japan 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
CHINA
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 24: China Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 25: China 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
EUROPE
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: Europe 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 29: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: Europe 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
FRANCE
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: France Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: France 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
GERMANY
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Germany Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: Germany 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Italy Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: Italy 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: UK Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: UK 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
SPAIN
  • Table 44: Spain Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Spain Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: Spain 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
RUSSIA
  • Table 47: Russia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Russia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Russia 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Rest of Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: Rest of Europe 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: Asia-Pacific 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: Asia-Pacific 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2023 & 2030
AUSTRALIA
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Keryx Biopharmaceuticals, Inc.
  • Luitpold Pharmaceuticals, Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedApril 2024
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 13.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.9 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal

Related Topics

Related Reports

Pharmaceutical Drugs Global Market Report 2024 - Product Image

Pharmaceutical Drugs Global Market Report 2024

  • Report
  • 400 Pages
  • Global
From
Asia-Pacific Pharmaceutical Industry Outlook 2023 - Product Image

Asia-Pacific Pharmaceutical Industry Outlook 2023

  • Report
  • 77 Pages
  • Asia Pacific
From
Drafting Effective Pharmaceutical Patents Training Course (May 13-16, 2024) - Product Image

Drafting Effective Pharmaceutical Patents Training Course (May 13-16, 2024)

  • Conference
  • 4 Days
  • Global
Iron Deficiency Anemia Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Iron Deficiency Anemia Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Global Iron Deficiency Anemia Therapy Market Analysis & Forecast to 2024-2034 - Product Image

Global Iron Deficiency Anemia Therapy Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.